These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 32647360)

  • 1. Obesity, the most common comorbidity in SARS-CoV-2: is leptin the link?
    Rebello CJ; Kirwan JP; Greenway FL
    Int J Obes (Lond); 2020 Sep; 44(9):1810-1817. PubMed ID: 32647360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
    Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Influenza Virus to Novel Corona Virus (SARS-CoV-2)-The Contribution of Obesity.
    Bhattacharya I; Ghayor C; Pérez Dominguez A; Weber FE
    Front Endocrinol (Lausanne); 2020; 11():556962. PubMed ID: 33123087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors.
    Stilhano RS; Costa AJ; Nishino MS; Shams S; Bartolomeo CS; Breithaupt-Faloppa AC; Silva EA; Ramirez AL; Prado CM; Ureshino RP
    FASEB J; 2020 Nov; 34(11):14103-14119. PubMed ID: 32965736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The endocrine and metabolic link between COVID-19, diabetes and obesity].
    Weis N; Thorsteinsson K; Martinussen C; Madsbad S
    Ugeskr Laeger; 2020 Jul; 182(29):. PubMed ID: 32734864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Collision of Meta-Inflammation and SARS-CoV-2 Pandemic Infection.
    Huizinga GP; Singer BH; Singer K
    Endocrinology; 2020 Nov; 161(11):. PubMed ID: 32880654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Incidence and Mortality from SARS-CoV-2 in Southern Europe. Proposal of a hypothesis for Arthropod borne Herd immunity.
    Balzan M
    Med Hypotheses; 2020 Oct; 143():110121. PubMed ID: 32759006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Severity in Obesity: Leptin and Inflammatory Cytokine Interplay in the Link Between High Morbidity and Mortality.
    Maurya R; Sebastian P; Namdeo M; Devender M; Gertler A
    Front Immunol; 2021; 12():649359. PubMed ID: 34220807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and obesity: links and risks.
    Lavie CJ; Sanchis-Gomar F; Henry BM; Lippi G
    Expert Rev Endocrinol Metab; 2020 Jul; 15(4):215-216. PubMed ID: 32441223
    [No Abstract]   [Full Text] [Related]  

  • 10. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19.
    El-Missiry MA; El-Missiry ZMA; Othman AI
    Eur J Pharmacol; 2020 Sep; 882():173329. PubMed ID: 32615182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.
    Bello-Chavolla OY; Bahena-López JP; Antonio-Villa NE; Vargas-Vázquez A; González-Díaz A; Márquez-Salinas A; Fermín-Martínez CA; Naveja JJ; Aguilar-Salinas CA
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32474598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses.
    Fung SY; Yuen KS; Ye ZW; Chan CP; Jin DY
    Emerg Microbes Infect; 2020; 9(1):558-570. PubMed ID: 32172672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term infection of SARS-CoV-2 changed the body's immune status.
    Lin L; Luo S; Qin R; Yang M; Wang X; Yang Q; Zhang Y; Wang Q; Zhu R; Fan H; Wang H; Hu Y; Wang L; Hu D
    Clin Immunol; 2020 Sep; 218():108524. PubMed ID: 32659373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: Crosstalk among calorie restriction, autophagy and immune response.
    Hannan MA; Rahman MA; Rahman MS; Sohag AAM; Dash R; Hossain KS; Farjana M; Uddin MJ
    Immunol Lett; 2020 Oct; 226():38-45. PubMed ID: 32659267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 entry in host cells-multiple targets for treatment and prevention.
    Mahmoud IS; Jarrar YB; Alshaer W; Ismail S
    Biochimie; 2020 Aug; 175():93-98. PubMed ID: 32479856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2-A Tough Opponent for the Immune System.
    Nasab MG; Saghazadeh A; Rezaei N
    Arch Med Res; 2020 Aug; 51(6):589-592. PubMed ID: 32532524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JAK Inhibition as a New Treatment Strategy for Patients with COVID-19.
    Seif F; Aazami H; Khoshmirsafa M; Kamali M; Mohsenzadegan M; Pornour M; Mansouri D
    Int Arch Allergy Immunol; 2020; 181(6):467-475. PubMed ID: 32392562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-Related Differences in Immunological Responses to SARS-CoV-2.
    Wong LSY; Loo EXL; Kang AYH; Lau HX; Tambyah PA; Tham EH
    J Allergy Clin Immunol Pract; 2020; 8(10):3251-3258. PubMed ID: 32861856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surviving COVID-19: A disease tolerance perspective.
    Ayres JS
    Sci Adv; 2020 May; 6(18):eabc1518. PubMed ID: 32494691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.